Home/Pipeline/BioCode STI + Resistance Panel

BioCode STI + Resistance Panel

Sexually Transmitted Infections with Antimicrobial Resistance

ResearchActive

Key Facts

Indication
Sexually Transmitted Infections with Antimicrobial Resistance
Phase
Research
Status
Active
Company

About Applied BioCode

Applied BioCode is a private, commercial-stage diagnostics company specializing in multiplex syndromic panel testing for infectious diseases. Its proprietary BioCode platform, centered on barcoded magnetic beads, enables high-throughput, cost-effective detection of multiple pathogens on its MDx-3000 instrument system. The company has an FDA-cleared gastrointestinal panel and a portfolio of research-use and development-stage panels for respiratory, fungal, and sexually transmitted infections, positioning it in the growing multiplex molecular diagnostics market. Its value proposition emphasizes operational efficiency, flexibility in test ordering, and maximizing insurance reimbursement.

View full company profile

Therapeutic Areas